Induction of Fetal Hemoglobin Synthesis With Recombinant Human Erythropoietin in Anemic Patients With Heterozygous Beta-Thalassemia During Pregnancy

References

• Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv 1994; 49: 129–135
   Google Scholar
• Mordel N, Birkenfeld A, Goldfarb A, Rachmilewitz E. Successful full term pregnancy in homozygous beta-thalassemia major: case report and review of the literature. Obstet Gynecol 1989; 73: 837–841
   PubMed Web of Science ®Google Scholar
• Schuman J, Tanser C, Peloquin R, Leeuw ND. The erythropoietic response to pregnancy in beta-thalassemia minor. Br J Haematol 1973; 25: 249–260
   PubMed Web of Science ®Google Scholar
• Ratten J, Beischer A. The significance of anemia in an obstetric population in Australia. J Obstet Gynaecol 1972; 79: 228–237
   Google Scholar
• White J, Richards R, Byrne M, Buchanan T, White Y, Jelenski G. Thalassemia trait and pregnancy. J Clin Pathol 1985; 38: 810–817
   PubMed Web of Science ®Google Scholar
• Necheles T. Obstetric complications associated with haemoglobinopathies. Clin Haematol 1973; 2: 497–513
   Google Scholar
• Junca J, Vela D, Orts M, Riutort N, Feliu E. Treating the anaemia of a pregnancy with heterozygous β thalassaemia with recombinant human erythropoietin. Eur J Haematol 1995; 55: 277–278
   PubMed Web of Science ®Google Scholar
• ACOG. Hemoglobinopathies in pregnancy. Int J Gynecol Obstet 1993; 43: 333–343
   Google Scholar
• Kilpatrick S, Laros R. Thalassemia in pregnancy. Clin Obstet Gynecol 1995; 38: 485–496
   Google Scholar
• Fleming A, Path M. Maternal anemia and fetal outcome in pregnancies complicated by thalassemia minor and “stomatocytosis.”. Am J Obstet Gynecol 1973; 116: 309–319
   PubMed Web of Science ®Google Scholar
• Morrison J, Morrison F. Rational use of blood products in obstetrics and gynecology. J Matern Fetal Invest 1994; 4: 147–153
   Google Scholar
• Gillon J, Greenburg A. Transfusion: infectious complications. Blood 1992; 54: 19–28
   Google Scholar
• Blau C, Stamatoyannopoulus G. Hemoglobin switching and its clinical implications. Curr Opin Hematol 1994; 1: 136–142
   PubMedGoogle Scholar
• Bourantas K, Georgiou I, Seferiadis K. Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients. Acta Haematol 1994; 92: 79–82
   Google Scholar
• Goldberg M, Brugnara C, Dover G, Schapira L, Charache S, Bunn F. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl] Med 1990; 323: 366–371
   PubMed Web of Science ®Google Scholar
• Nagel R, Vichinsky E, Shah M, Johnson R, Spadacino E, Fabry M, Mangahas L, Abel R, Stamatoyannopoulos G. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood 1993; 81: 9–14
   PubMed Web of Science ®Google Scholar
• Rachmilewitz E, Goldfarb A, Dover G. Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. Blood 1991; 78: 1145–1147
   Google Scholar
• Rachmilewitz E, Aker M, Perry D, Dover G. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassemia. Br J Haematol 1995; 90: 341–345
   PubMed Web of Science ®Google Scholar
• Rodgers G, Dover G, Uyesaka N, Noguchi C, Schechter A, Nienhuis A. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993; 328: 73–80
   PubMed Web of Science ®Google Scholar
• Leroy-Viard K, Fessard P, Beuzard Y. Improvement of mouse beta-thalassemia by recombinant human erythropoietin. Blood 1991; 78: 1596–1602
   Google Scholar
• Malek A, Sager R, Eckardt K, Scholz H, Bauer C, Schneider H. Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system. Pfliigers Arch 1994; 427: 157–161
   PubMed Web of Science ®Google Scholar
• Widness J, Malone T, Mufson R. Impermeability of the ovine placenta to S-recombinant erythropoietin. Pediatr Res 1989; 25: 649–651
   PubMedGoogle Scholar
• Hou S, Orlowski J, Pahl M, Ambrose S, Hussey M, Wong D. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 1993; 21: 16–21
   PubMed Web of Science ®Google Scholar
• Braga J, Marques R, Branco A, Goncalves J, Lobato L, Pimentel J, Flores M, Goncalves E, Jorge C. Maternal and perinatal implications of the use of recombinant erythropoietin. Acta Obstet Gynecol Scand 1996; 75: 449–153
   PubMed Web of Science ®Google Scholar
• McGregor E, Stewart G, Junor B, Rodger R. Successful use of recombinant human erythropoietin in pregnancy. Nephrol Dial Transplant 1991; 6: 292–293
   PubMedGoogle Scholar
• Yankowitz J, Praino B, Laifer S, Frassetto L, Gavin L, Kitzmiller J, Crombleholme W. Erythropoietin in pregnancies complicated by severe anemia of renal failure. Obstet Gynecol 1992; 80: 485–488
   Google Scholar
• Breymann C, Major A, Richter C, Huch R, Huch A. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study. J Perinat Med 1995; 23: 89–98
   Google Scholar
• Breymann C, Zimmermann R, Huch R, Huch A. Use of rhEPO in combination with parenteral iron for the treatment of postpartum anemia. Eur] Clin Invest 1996; 23: 123–126
   Google Scholar
• Breymann C, Bauer C, Zimmermann R, Gautschi K, Major A, Huch R, Huch A. Optimal timing of repeated erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. BrJ Haematol 1996; 92: 295–301
   Google Scholar
• Fibach E, Burke L, Schechter A, Noguchi C, Rodgers P. Hydroxyurea increases fetal haemoglobin in cultured erythroid cells derived from normal and patients with sickle cell anemia or beta-thalassemia. Blood 1993; 81: 1630–1635
   PubMed Web of Science ®Google Scholar
• Dover G, Boyer S. Fetal hemoglobin containing cells have the same mean corpuscular hemoglobin as cells without fetal hemoglobin: a reciprocal relationship between gamma- and beta-globin expression in normal subjects and those with high fetal hemoglobin production. Blood 1987; 69: 1109–1113
   PubMed Web of Science ®Google Scholar
• Epstein N, Epstein M, Boulet A, Fibach E, Rodgers P. Monoclonal antibody based methods for quantitation of hemoglobins: application to evaluating patients with sickle cell anemia treated with hydroxyurea. Eur J Haematol 1996; 57: 17–24
   Google Scholar
• Tanke H, Nieuwenhuis I, Koper G, Slats J, Ploem J. Flow cytometry of human reticulocytes based on RNA-fluorescence. Cytometry 1980; 1: 313–320
   Google Scholar
• Tanke H, Rothbarth P, Vossen J, Koper G, Ploem J. Flow cytometry of reticulocytes applied to clinical hematology. Blood 1983; 61: 1091–1097
   PubMed Web of Science ®Google Scholar
• Brugnara C, Colella G, Cremins J, Langley R, Schneider T, Rutherford C, Goldberg M. Effects of subcutaneous recombinant erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron deficient erythropoiesis. J Lab Clin Med 1994; 123: 660–666
   PubMed Web of Science ®Google Scholar
• d'Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85: 818–823
   PubMed Web of Science ®Google Scholar
• McDougall I, Cavill I, Hulme B, Bain B, Gregor E, Kay P. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med] 1992; 304: 225–226
   PubMed Web of Science ®Google Scholar
• Dore F, Gaviano E, Bonfigli S, Pardini S, Pistidda P, Guiso L, Longinotti M. Low doses of rhuEPO administered to adult patients with thalassemia intermedia. Ann Hematol 1994; 69: 211–212
   Google Scholar
• Cozma G, Cozma M, Mattes U. Beneficial effect of rhEPO in beta-thalassemia patients on dialysis. Nephrol Dial Transplant 1992; 7: 82–85
   Google Scholar
• Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. Fetal Hb production during acute erythroid expansion; observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol 1980; 44: 535–546
   PubMed Web of Science ®Google Scholar
• Blau C, Constantoulakis P, Al-Khatti A, Spadacino E, Goldwasser E, Papayannopoulou T, Stamatoyannopoulos G. Fetal hemoglobin in acute and chronic states of erythroid expansion. Blood 1993; 81: 227–233
   PubMed Web of Science ®Google Scholar
• Fibach E, Schechter N, Noguchi C, Rodgers G. Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin. Br J Haematol 1994; 88: 39–15
   PubMedGoogle Scholar
• Cazzola M, Mercuriali F, Brugnara C. Use of recombinant erythropoietin outside the setting of uremia. Blood 1997; 89: 4248–4267
   PubMedGoogle Scholar
• McDonagh K, Dover G, Donahue R, Nathan D, Agricola B, Byrne E, Nienhuis A. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors and sodium butyrate. Exp Hematol 1992; 20: 1156–1164
   PubMed Web of Science ®Google Scholar
• Olivieri N, Freedman M, Perrine S, Dover G, Sheridan B, Essentine D, Nagel R. Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood 1992; 80: 3258–3260
   Google Scholar